These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9698216)

  • 1. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
    Ribas C; Miralles A; Escribá PV; García-Sevilla JA
    Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain.
    Miralles A; Ribas C; Escribá PV; García-Sevilla JA
    Pharmacol Toxicol; 2000 Dec; 87(6):269-75. PubMed ID: 11140825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
    Ribas C; Miralles A; García-Sevilla JA
    Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Adler CH; Meller E; Goldstein M
    Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covariation of alpha 2-adrenoceptor density and function following irreversible antagonism with EEDQ.
    Durcan MJ; Morgan PF; Van Etten ML; Linnoila M
    Br J Pharmacol; 1994 Jul; 112(3):855-60. PubMed ID: 7921612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
    Miralles A; Ribas C; Olmos G; García-Sevilla JA
    J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.
    Ribas C; Miralles A; Busquets X; García-Sevilla JA
    Br J Pharmacol; 2001 Apr; 132(7):1467-76. PubMed ID: 11264240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
    Barturen F; Garcia-Sevilla JA
    Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust GTP-induced shift in alpha(2)-adrenoceptor agonist affinity in tissue sections from rat brain.
    Bylund DB; Gerety ME; Happe HK; Murrin LC
    J Neurosci Methods; 2001 Feb; 105(2):159-66. PubMed ID: 11275272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Pilc A; Vetulani J; Nomura S; Enna SJ
    Brain Res; 1989 Jul; 493(1):8-13. PubMed ID: 2570619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of cholinesterase inhibitors and pilocarpine on the density and sensitivity of central and peripheral alpha 2-adrenoceptors.
    Olmos G; Miralles A; García-Sevilla JA; Giralt MT; Pineda J; Asier Garro M; Ugedo L; Menargues A; Obach R
    Eur J Pharmacol; 1993 Jun; 236(3):467-76. PubMed ID: 8102972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
    Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
    Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
    Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
    Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central alpha 2-autoreceptors: agonist dissociation constants and recovery after irreversible inactivation.
    Agneter E; Drobny H; Singer EA
    Br J Pharmacol; 1993 Feb; 108(2):370-5. PubMed ID: 8095417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.